Implantable Drug Delivery Market: Global Industry Analysis and Forecast (2021-2027): By Product Type, Technology, Application and Region

Implantable Drug Delivery Market is anticipated to reach US$ 39.16 Bn. by 2027 from US$ 22.85 Bn. in 2020 at a CAGR of 8 % during a forecast period. Implantable drug delivery systems are medical devices that allow for site-specific medication administration. It also allows for the decrease of medicine dosages to reduce potential negative effects. Because of the site-specific and sustained release therapeutic activity, implantable devices are gaining attention in comparison to the conservative oral and parenteral dose forms. Implantable devices, in turn, lessen the side effects associated with the medicine. Implantable Drug Delivery Market To know about the Research Methodology:- Request Free Sample Report In the report, 2020 is considered a base year however 2020’s numbers are on the real output of the companies in the market. Special attention is given to 2020 and the effect of lockdown on the demand and supply, and also the impact of lockdown for the next two years on the market. Some companies have done well in lockdown also and specific strategic analysis of those companies is done in the report.

Implantable Drug Delivery Market Dynamics:

Over the forecast period, the Implantable Drug Delivery Market is likely to be driven by an increase in demand for less invasive medical treatments, as well as the rising incidence of chronic illnesses and other medical concerns. Government attempts to raise awareness and financing for the pharmaceutical and biotech sectors are also key market drivers. Additionally, the market is expected to be fuelled by the expanding elderly population and the launch of new and more effective Implantable Drug Delivery devices throughout the forecasted period. Implantable drug delivery devices provide various advantages over traditional oral or parenteral dose forms, including protection from gastrointestinal tract denaturation and increased absorption across the intestinal or stomach wall. Second, to have the intended therapeutic impact, the volume of medicine reaching the target should be large. Another factor that increases patient acceptance and compliance over traditional drug administration is biodegradable systems, which have gained traction over non-biodegradable delivery systems because the inert polymer used in device fabrication eventually gets absorbed and excreted by the body, eliminating the need for surgical implant removal after therapy. Over the forecast period, these factors are likely to drive market growth. There are several constraints and problems that might hamper market expansion. Market limitations are likely to include things like the likelihood of implanted device malfunctions and severe regulatory controls.

Implantable Drug Delivery Market Segmentation Analysis:

By Product Type, Because of the rising incidence of peripheral and coronary artery diseases, increasing patient-controlled devices, shifting effort of manufacturers on clinical trials related to bioresorbable stents, growing adoption by patients and physicians, and rising demand for minimally invasive surgeries, the bioabsorbable stents market is expected to grow at an exponential CAGR of xx percent over the forecast period. In the future periods, the increased demand for innovative birth control methods is expected to drive up demand for contraceptive implants. Once implanted, these devices can help prevent pregnancy for a while. This lowers the need for contraceptive pills, as well as the negative side effects that come with them. As a result, the negative consequences of several existing birth control techniques are expected to fuel demand for contraceptive implants throughout the forecast period. By Application, Cardiovascular applications are expected to account for the highest share of the market throughout the forecast period, owing to a growing patient population suffering from cardiovascular disorders, which increases the clinical urgency to create better devices. As a result, worldwide leading players have created bio-absorbable stents that are gradually absorbed and expelled by the body. Multiple sclerosis and rheumatoid arthritis are included in the other part. This segment's key growth driver is the rising prevalence of multiple sclerosis. Multiple sclerosis is thought to be one of the primary causes of non-traumatic impairment. This condition is believed to affect roughly 2.5 million people throughout the world. More than 400,000 individuals have been diagnosed with this ailment in the United States, according to CDC data, with an average rise of 200 cases each week. Only 10.0 percent of patients are diagnosed after the age of 50, with the typical age of onset being 30 to 33 years.

Implantable Drug Delivery Market Regional Insight

Due to increased research & development efforts in the area, North America is likely to have a dominating position in the implanted drug delivery devices market. The medical device business in North America is a highly regulated sector of the economy. Several studies imply that US implanted device makers can keep their costs high owing to structural constraints such as expensive regulatory approval processes and patent protections. As a result, companies are having difficulty introducing new products in the United States. During the forecast period, Asia Pacific is expected to grow at an exponential rate, owing to rising healthcare spending and increased awareness of the benefits of implanted drug delivery devices. Improving regulatory rules that maintain high safety standards and the quality of healthcare facilities are also anticipated to grow the region's economic potential. China and India come in second and third, respectively, in the worldwide market for implanted drug delivery systems after North America and Europe. Due to increased awareness and increased government healthcare budgets, India and China are expected to demonstrate lucrative growth in the worldwide market in the Asia Pacific region. The favourable environment and availability are another cause for the rapid growth of the implanted medication delivery market in India and China.

Report Objectives:

• Landscape analysis of the Implantable Drug Delivery Market • competitive benchmarking • Past and current status of the industry with the forecasted market size and trends • Evaluation of potential key players that include market leaders, followers, and new entrants • Technology trends • Potential impact of micro-economic factors of the market • External and Internal factors affecting market have been analysed The report also helps in understanding the Implantable Drug Delivery Market dynamics, structure by analysing the market segments and project the Implantable Drug Delivery Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Implantable Drug Delivery Market make the report investor’s guide.

Implantable Drug Delivery Market Scope: Inquire before buying

Implantable Drug Delivery Market
Report Coverage Details
Base Year: 2020 Forecast Period: 2021-2027
Historical Data: 2016 to 2020 Market Size in 2020: US $ 22.85 Bn.
Forecast Period 2021 to 2027 CAGR: 8 % Market Size in 2027: US $ 39.16 Bn.
Segments Covered: by Product Type • Implantable Bio-Absorbable Stents • Implantable Contraceptive Drug Delivery Devices • Implantable Intraocular Drug Delivery Devices • Implantable Coronary Drug-Eluting Stents • Implantable Brachytherapy Seeds • Implantable Drug Infusion Pumps
by Technology • Biodegradable implantable drug delivery device technology • Non-biodegradable implantable drug delivery device technology
by Application • Cardiovascular • Birth control & contraception • Ophthalmology • Oncology • Others

Implantable Drug Delivery Market, by Region

• North America • Asia pacific • Europe • Middle East and Africa • South America

Implantable Drug Delivery Market Key Players

• Bayer • Boston Scientific • Medtronic • Merck&Co. Inc. • Allergan Inc. • Bausch and Lomb, Inc. • Ithetis • Nucletron • Genetech Inc. • Theragenics • Psivida • Kinamed Inc. • K2M Inc. • Mako Surgical Corp. • Varian Medical System • Arrow International • Eckert Ziegler • Elekta • JVS • Abbottamong • Delpor Inc. • 3M Company • DSM Biomedical • Alimera Sciences

Frequently Asked Questions

1. What is the projected market size & growth rate of Implantable Drug Delivery Market? Ans- Implantable Drug Delivery Market was valued at USD 22.85 billion in 2020 and is projected to reach USD 39.16 billion by 2027, growing at a CAGR of 8 % during the forecast period. 2. What are the key driving factors for the growth of Implantable Drug Delivery Market? Ans- Over the forecast period, the Implantable Drug Delivery Market is likely to be driven by an increase in demand for less invasive medical treatments, as well as the rising incidence of chronic illnesses and other medical concerns. 3. Which Region accounted for the largest Implantable Drug Delivery Market share? Ans- Due to increased research & development efforts in the area, North America is likely to have a dominating position in the implanted drug delivery devices market. 4. What makes Asia Pacific a Lucrative Market for Implantable Drug Delivery Market? Ans- Asia Pacific is expected to grow at an exponential rate, owing to rising healthcare spending and increased awareness of the benefits of implanted drug delivery devices. 5. What are the top players operating in Implantable Drug Delivery Market? Ans- Bayer, Boston Scientific, Medtronic, Merck&Co. Inc., Allergan Inc., Bausch and Lomb, Inc., and Ithetis.
1. Global Implantable Drug Delivery Market: Research Methodology 2. Global Implantable Drug Delivery Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Implantable Drug Delivery Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Implantable Drug Delivery Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Implantable Drug Delivery Market Segmentation 4.1 Global Implantable Drug Delivery Market, By Product Type (2020-2027) • Implantable Bio-Absorbable Stents • Implantable Contraceptive Drug Delivery Devices • Implantable Intraocular Drug Delivery Devices • Implantable Coronary Drug Eluting Stents • Implantable Brachytherapy Seeds • Implantable Drug Infusion Pumps 4.2 Global Implantable Drug Delivery Market, By Technology (2020-2027) • Biodegradable implantable drug delivery device technology • Non-biodegradable implantable drug delivery device technology 4.3. European Implantable Drug Delivery Market, By Application (2020-2027) • Cardiovascular • Birth control & contraception • Ophthalmology • Oncology • Others 5. North America Implantable Drug Delivery Market (2020-2027) 5.1 North American Implantable Drug Delivery Market, By Product Type (2020-2027) • Implantable Bio-Absorbable Stents • Implantable Contraceptive Drug Delivery Devices • Implantable Intraocular Drug Delivery Devices • Implantable Coronary Drug-Eluting Stents • Implantable Brachytherapy Seeds • Implantable Drug Infusion Pumps 5.2 North America Implantable Drug Delivery Market, By Technology (2020-2027) • Biodegradable implantable drug delivery device technology • Non-biodegradable implantable drug delivery device technology 5.3. European Implantable Drug Delivery Market, By Application (2020-2027) • Cardiovascular • Birth control & contraception • Ophthalmology • Oncology • Others 5.4 North America Implantable Drug Delivery Market, by Country (2020-2027) • United States • Canada • Mexico 6. Asia Pacific Implantable Drug Delivery Market (2020-2027) 6.1. Asia Pacific Implantable Drug Delivery Market, By Product Type (2020-2027) 6.2. Asia Pacific Implantable Drug Delivery Market, By Technology (2020-2027) 6.3. European Implantable Drug Delivery Market, By Application (2020-2027) 6.4. Asia Pacific Implantable Drug Delivery Market, by Country (2020-2027) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Implantable Drug Delivery Market (2020-2027) 7.1. Middle East and Africa Implantable Drug Delivery Market, By Product Type (2020-2027) 7.2. Middle East and Africa Implantable Drug Delivery Market, By Technology (2020-2027) 7.3. European Implantable Drug Delivery Market, By Application (2020-2027) 7.4. Middle East and Africa Implantable Drug Delivery Market, by Country (2020-2027) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Implantable Drug Delivery Market (2020-2027) 8.1. Latin America Implantable Drug Delivery Market, By Product Type (2020-2027) 8.2. Latin America Implantable Drug Delivery Market, By Technology (2020-2027) 8.3. European Implantable Drug Delivery Market, By Application (2020-2027) 8.4 Latin America Implantable Drug Delivery Market, by Country (2020-2027) • Brazil • Argentina • Rest Of Latin America 9. European Implantable Drug Delivery Market (2020-2027) 9.1. European Implantable Drug Delivery Market, By Product Type (2020-2027) 9.2. European Implantable Drug Delivery Market, By Technology (2020-2027) 9.3. European Implantable Drug Delivery Market, By Application (2020-2027) 9.4 European Implantable Drug Delivery Market, by Country (2020-2027) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Keir Surgical 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.16. Recent Developments 10.2. Bayer 10.3. Boston Scientific 10.4. Medtronic 10.5. Merck&Co. Inc. 10.6. Allergan Inc. 10.7. Bausch and Lomb, Inc. 10.8. Ithetis 10.9. Nucletron 10.10. Genetech Inc. 10.11. Theragenics 10.12. Psivida 10.13. Kinamed Inc. 10.14. K2M Inc. 10.15. Mako Surgical Corp. 10.16. Varian Medical System 10.17. Arrow International 10.18. Eckert Ziegler 10.19. Elekta 10.20. JVS 10.21. Abbottamong 10.22. Delpor Inc. 10.23. 3M Company 10.24. DSM Biomedical 10.25. Alimera Sciences

About This Report

Report ID 14711
Category Healthcare
Published Date sep 2019
Updated Date Jan 2022
Contact Us